RECENT PLACEMENT

Occam Recruits CBO for Parisian Generative AI Drug Discovery Platform Company, Iktos

Occam Recruits CBO for Parisian Generative AI Drug Discovery Platform Company, Iktos

In January 2024, Occam recruited Avirup Bose, Ph.D., as Chief Business Officer of Iktos, a Paris-based biotech leveraging Artificial Intelligence for new drug design and an M Ventures investment. 

 

Avirup previously served as VP of Business Development at Chinook Therapeutics (NASDAQ: KDNY), where he was instrumental in engineering many important strategic collaboration agreements.  Chinook was acquired by Novartis in 2023.  Prior to Chinook, Bose spent 17 years at Novartis, where he held positions of increasing responsibility in research, portfolio management, licensing, and business development.  

 

Occam is a globally recognized leader in recruiting AI innovators for the life sciences.   Check out Occam President John Holdonak's recent blog on the AI-ML Revolution in Drug R&D. 

‍

Related Placements

  1. Suzanne “Sue” Bruhn CEO of Prominent Rare Disease Research Foundation
  2. Vatnak Vat-Ho as CBO at Ryvu Therapeutics
  3. Steve Colletti as CSO of Korro Bio
  4. Theo Karaletsos as VP, Data Science/ML at insitro
  5. Sana Hafeez as Head of People at Unlearn
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.